DOCSLIB.ORG
  • Sign Up
  • Log In
  • Upload
  • Sign Up
  • Log In
  • Upload
  • Home
  • »  Tags
  • »  Pimecrolimus

Pimecrolimus

  • Updates in Pediatric Dermatology

    Updates in Pediatric Dermatology

  • Pimecrolimus for the Treatment of Adults with Atopic Dermatitis, Seborrheic Dermatitis, Or Psoriasis: a Review of Clinical and Cost- Effectiveness

    Pimecrolimus for the Treatment of Adults with Atopic Dermatitis, Seborrheic Dermatitis, Or Psoriasis: a Review of Clinical and Cost- Effectiveness

  • Aetna Formulary Exclusions Drug List

    Aetna Formulary Exclusions Drug List

  • Pimecrolimus Cream 1% PI

    Pimecrolimus Cream 1% PI

  • Estonian Statistics on Medicines 2016 1/41

    Estonian Statistics on Medicines 2016 1/41

  • Patent Application Publication ( 10 ) Pub . No . : US 2019 / 0192440 A1

    Patent Application Publication ( 10 ) Pub . No . : US 2019 / 0192440 A1

  • Evidence-Based Danish Guidelines for the Treatment of Malassezia- Related Skin Diseases

    Evidence-Based Danish Guidelines for the Treatment of Malassezia- Related Skin Diseases

  • The Rx Consultant Index to Volume XVIII (2009 Issues)

    The Rx Consultant Index to Volume XVIII (2009 Issues)

  • Estonian Statistics on Medicines 2013 1/44

    Estonian Statistics on Medicines 2013 1/44

  • ELIDEL* (Pimecrolimus)

    ELIDEL* (Pimecrolimus)

  • List of Formulary Drug Removals

    List of Formulary Drug Removals

  • A New Treatment for Seborrheic Dermatitis

    A New Treatment for Seborrheic Dermatitis

  • Therapeutic Class Overview Topical Immunomodulators

    Therapeutic Class Overview Topical Immunomodulators

  • COMPARISON of the WHO ATC CLASSIFICATION & Ephmra/Intellus Worldwide ANATOMICAL CLASSIFICATION

    COMPARISON of the WHO ATC CLASSIFICATION & Ephmra/Intellus Worldwide ANATOMICAL CLASSIFICATION

  • ELIDEL (Pimecrolimus) Cream 1% to the Affected Skin Twice Daily

    ELIDEL (Pimecrolimus) Cream 1% to the Affected Skin Twice Daily

  • Reseptregisteret 2014–2018 the Norwegian Prescription Database 2014–2018

    Reseptregisteret 2014–2018 the Norwegian Prescription Database 2014–2018

  • Your 2021 Premium Value Formulary Effective July 1, 2021

    Your 2021 Premium Value Formulary Effective July 1, 2021

  • Seborrheic Dermatitis and Its Relationship with Malassezia Spp

    Seborrheic Dermatitis and Its Relationship with Malassezia Spp

Top View
  • Protocol for Prescribing Of
  • Shared Care Guidelines for Prescribing Atomoxetine (Strattera®) in Children and Adolescents
  • Topical Calcineurin Inhibitor Task Force Report
  • Elidel (Pimecrolimus) and Protopic (Tacrolimus)
  • Faa-Meds.Pdf
  • Seborrheic Dermatitis and Its Relationship with Malassezia Spp
  • Study Protocol
  • Topical Tacrolimus Or Pimecrolimus for the Treatment of Mild, Moderate Or Severe Atopic Eczema
  • Dandruff and Seborrheic Dermatitis: a Head Scratcher James R
  • Trends in Atopic Dermatitis—From Standard Pharmacotherapy to Novel Drug Delivery Systems
  • Gpi Drug Classification Report
  • Mdwise Formulary Introduction – Healthy Indiana Plan Basic (HIP Basic)
  • VA Anthem Common Core Formulary
  • Apis, Excipients, & Manufacturing
  • (12) Patent Application Publication (10) Pub. No.: US 2014/0135361 A1 Lin Et Al
  • Safe and Effective Treatment of Seborrheic Dermatitis
  • Previous Versions
  • Assessment Report


© 2024 Docslib.org    Feedback